KIORA PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $14.6M | $7.9M |
| FY2022 | — | $11.4M | $6.0M |
| FY2023 | — | $6.1M | $2.5M |
| FY2024 | — | $25.8M | $3.8M |
| FY2025 | — | $16.1M | $8.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $14.6M | $7.9M |
| FY2022 | — | $11.4M | $6.0M |
| FY2023 | — | $6.1M | $2.5M |
| FY2024 | — | $25.8M | $3.8M |
| FY2025 | — | $16.1M | $8.7M |